Guardant Health
GH
#1137
Rank
NZ$36.64 B
Marketcap
NZ$273.05
Share price
-4.17%
Change (1 day)
138.82%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2026 (TTM): NZ-$5.79

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is NZ-$5.73. In 2025 the company made an earnings per share (EPS) of NZ-$5.60 an increase over its 2024 EPS that were of NZ-$6.02.

EPS history for Guardant Health from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$5.793.52%
2025NZ-$5.60-7.02%
2024NZ-$6.02-16.82%
2023NZ-$7.24-33.13%
2022NZ-$10.8260%
2021NZ-$6.7655.04%
2020NZ-$4.36207.14%
2019NZ-$1.42-19.81%
2018NZ-$1.77

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
NZ-$4.75-17.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
NZ-$4.19-26.84%๐Ÿ‡บ๐Ÿ‡ธ USA